For the TIM, previous studies have established radiomic models to predict immune signatures in solid tumors [25, 26], including the expression level of immune checkpoint molecules such as PD-L1 [11] and counts of tumor-infiltrating immune cells such as CD8+ T cells [10]. This evidence concerns the gene CD8A and neoplasm.